J&J’s Rybrevant Receives FDA Nod for Expanded Use in NSCLC
ZacksWith this approval, JNJ’s Rybrevant is now approved for a total of four indications in the United States.
With this approval, JNJ’s Rybrevant is now approved for a total of four indications in the United States.